From R&D to market
IP and regulatory strategy across the product life cycle
What is it about?
This webinar follows the stages of a product’s life cycle, explaining how structured, science-based development and intellectual property considerations support regulatory alignment and long-term value creation.
Watch the recording and gain actionable insights at your own pace!
What will you learn?
- How to manage a product strategically throughout its full life cycle
- The role of Quality by Design in development and regulatory pathways
- How IP and regulatory strategies interact across product stages
- Practical insights from real-life industry cases
Watch here
Who should attend?
This webinar targets R&D-driven organizations and professionals responsible for development strategy, quality by design implementation, and regulatory alignment across the product life cycle.
Speakers
Anne-Sophie Grell
A regulatory and quality affairs specialist with deep expertise in MDR compliance and international medical device regulations. Anne-Sophie supports companies in navigating complex regulatory landscapes, including FDA, Anvisa, Shonin, and CE marking requirements. She has extensive experience in post-market vigilance, complaint handling, and compliance for medical devices, with technical expertise in radioprotection, medical physics, and X-ray/MRI technologies. With a background in managing multicultural business environments, she is an expert in problem-solving, project management, and regulatory affairs strategy.
Stijn Lagaert
Stijn brings extensive expertise across biotechnology, pharmaceutical chemistry, plant protection products, fertilizers, and food and feed technologies. He is highly skilled in the drafting and prosecution of European and international patent applications and provides strategic advice on filing strategies, patentability assessments, and freedom-to-operate studies. With significant experience in due diligence, he excels at evaluating third-party patent portfolios and optimizing clients’ portfolios for due diligence evaluations. Stijn is also a seasoned advocate in opposition and appeal proceedings before the European Patent Office. Additionally, he is a recognized authority on Supplementary Protection Certificates (SPCs) for pharmaceuticals and agricultural products, qualified to represent clients before the Unitary Patent Office, and a registered Court Expert in Belgium for patent matters, including seizure procedures for suspected patent infringements.
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
.png?width=656&height=369&name=logo%20(1).png)